[Expression profile of miR-501-5p in lung adenocarcinoma patients from Xuanwei area].
Shuai Chen(Fujian Medical University), Yunchao Huang(North China University of Water Resources and Electric Power), Guangjian Li(Hohai University), Xiaobo Chen, Ying Chen(Inner Mongolia University), Guangqiang Zhao(Kunming Medical University), Yujie Lei(Kunming Medical University), Qiubo Huang, Yongchun Zhou(Kunming Medical University), Linwei Tian(Fuzhou University)
Cited by 8
Related Papers
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
|The Lancet Oncology|2015|1.6k
High speed BLASTN: an accelerated MegaBLAST search tool
|Nucleic Acids Research|2015|746
Global Variation in the Effects of Ambient Temperature on Mortality
|Epidemiology|2014|618
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|508
Temperature Variability and Mortality: A Multi-Country Study
|Environmental Health Perspectives|2016|335